Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

DXA Precision and Accuracy Comparison Study
DXA Precision and Accuracy Comparison Study
Status: Enrolling
Updated:  11/15/2015
Colorado Center for Bone Research
mi
from
Lakewood, CO
DXA Precision and Accuracy Comparison Study
DXA Precision and Accuracy Comparison Study
Status: Enrolling
Updated: 11/15/2015
Colorado Center for Bone Research
mi
from
Lakewood, CO
Click here to add this to my saved trials
B-Receptor Signaling in Cardiomyopathy
B-Receptor Signaling in Cardiomyopathy
Status: Enrolling
Updated:  11/16/2015
Stanford University School of Medicine
mi
from
Stanford, CA
B-Receptor Signaling in Cardiomyopathy
B-Receptor Signaling in Cardiomyopathy
Status: Enrolling
Updated: 11/16/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
P400 for Stage II-IV Pressure Ulcers in Home and Extended Care
Assessment of the Incidence and Treatment of Stage II -IV Pressure Ulcers in the Home Care or Extended Care Environments Utilizing the P400 Mattress
Status: Enrolling
Updated:  11/16/2015
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
P400 for Stage II-IV Pressure Ulcers in Home and Extended Care
Assessment of the Incidence and Treatment of Stage II -IV Pressure Ulcers in the Home Care or Extended Care Environments Utilizing the P400 Mattress
Status: Enrolling
Updated: 11/16/2015
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs
A Prospective, Open, Comparative, Randomized, Single-centre Study to Evaluate the Effect of Cadexomer Iodine Gel (IODOSORB) Compared to Standard Dressings (SOLOSITE) on Biofilm Disruption in Infected Diabetic Foot Ulcers (DFUs)
Status: Enrolling
Updated:  11/16/2015
St. Luke's Roosevelt Hospital
mi
from
New York, NY
A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs
A Prospective, Open, Comparative, Randomized, Single-centre Study to Evaluate the Effect of Cadexomer Iodine Gel (IODOSORB) Compared to Standard Dressings (SOLOSITE) on Biofilm Disruption in Infected Diabetic Foot Ulcers (DFUs)
Status: Enrolling
Updated: 11/16/2015
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis
Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis
Status: Enrolling
Updated:  11/16/2015
Stanford Hospital and Clinics
mi
from
Palo Alto, CA
Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis
Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis
Status: Enrolling
Updated: 11/16/2015
Stanford Hospital and Clinics
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
Status: Enrolling
Updated:  11/16/2015
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
Status: Enrolling
Updated: 11/16/2015
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy
Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy
Status: Enrolling
Updated:  11/17/2015
Baystate Medical Center
mi
from
Springfield, MA
Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy
Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy
Status: Enrolling
Updated: 11/17/2015
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
A Phase 2a Study of an Anti-LOXL2 Monoclonal Antibody (GS-6624) in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Status: Enrolling
Updated:  11/17/2015
NIH Department of Laboratory Medicine
mi
from
Bethesda, MD
A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
A Phase 2a Study of an Anti-LOXL2 Monoclonal Antibody (GS-6624) in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/17/2015
NIH Department of Laboratory Medicine
mi
from
Bethesda, MD
Click here to add this to my saved trials
Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients
Status: Enrolling
Updated:  11/17/2015
Substance Use Research Unit
mi
from
San Francisco, CA
Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients
Status: Enrolling
Updated: 11/17/2015
Substance Use Research Unit
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Mission Viejo, CA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Newport Beach, CA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Bridgeport, CT
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Melbourne, FL
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Melbourne, FL
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Winter Park, FL
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Chicago, IL
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Kansas City, KA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Biddeford, ME
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Biddeford, ME
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Boston, MA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
St Louis, MO
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Concord, NH
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Concord, NH
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
New York, NY
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Charlotte, NC
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Durham, NC
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Cincinnati, OH
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Franklin, OH
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Franklin, OH
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Portland, OR
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Nashville, TN
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Dallas, TX
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
mi
from
Seattle, WA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Investigational Site Number 076004
mi
from
São Paulo,
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Investigational Site Number 076004
mi
from
São Paulo,
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
UCSD Department of Surgery
mi
from
San Diego, CA
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
UCSD Department of Surgery
mi
from
San Diego, CA
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Indiana University
mi
from
Indianapolis, IN
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Washington University
mi
from
St. Louis, MO
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Greenville Hospital System
mi
from
Greenville, SC
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Greenville Hospital System
mi
from
Greenville, SC
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Mount Sinai Medical Center
mi
from
New York City, NY
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Mount Sinai Medical Center
mi
from
New York City, NY
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Case Medical Center, Case Western Reserve University, Case Western Reserve University
mi
from
Cleveland, OH
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Case Medical Center, Case Western Reserve University, Case Western Reserve University
mi
from
Cleveland, OH
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Canisius-Wilhelmina Ziekenhuis
mi
from
Nijmegen,
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Canisius-Wilhelmina Ziekenhuis
mi
from
Nijmegen,
Click here to add this to my saved trials
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
Tumor Necrosis Factor Alpha Inhibitor (Lnfliximab, Adalimumab) Treatment for Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences
Status: Enrolling
Updated:  11/19/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
Tumor Necrosis Factor Alpha Inhibitor (Lnfliximab, Adalimumab) Treatment for Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences
Status: Enrolling
Updated: 11/19/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Status: Enrolling
Updated:  11/20/2015
Holtz's Children's Hospital- University of Miami/Jackson Memorial Hospital
mi
from
Miami, FL
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Status: Enrolling
Updated: 11/20/2015
Holtz's Children's Hospital- University of Miami/Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Orlando, FL
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
mi
from
Knoxville, TN
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Status: Enrolling
Updated:  11/23/2015
The Mayo Clinic
mi
from
Rochester, MN
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Status: Enrolling
Updated: 11/23/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Analgesia in Children Using Caudal Epidural Ropivacaine
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study
Status: Enrolling
Updated:  11/23/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Analgesia in Children Using Caudal Epidural Ropivacaine
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study
Status: Enrolling
Updated: 11/23/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Analgesia in Children Using Caudal Epidural Ropivacaine
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study
Status: Enrolling
Updated:  11/23/2015
Loma Linda University Outpatient Surgery Center
mi
from
Loma Linda, CA
Analgesia in Children Using Caudal Epidural Ropivacaine
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study
Status: Enrolling
Updated: 11/23/2015
Loma Linda University Outpatient Surgery Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/23/2015
Institute for Advanced Wound Care
mi
from
Montgomery, AL
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/23/2015
Institute for Advanced Wound Care
mi
from
Montgomery, AL
Click here to add this to my saved trials
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/23/2015
HealthEast Care System, Inc
mi
from
St. Paul, MN
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/23/2015
HealthEast Care System, Inc
mi
from
St. Paul, MN
Click here to add this to my saved trials
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/23/2015
Jobst Vascular Institute
mi
from
Toledo, OH
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/23/2015
Jobst Vascular Institute
mi
from
Toledo, OH
Click here to add this to my saved trials
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/23/2015
Lawson Health Research Institute
mi
from
London,
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/23/2015
Lawson Health Research Institute
mi
from
London,
Click here to add this to my saved trials